Author: administrator

Smart Pulse Oximeters Market: Awareness Drives for Treatment of COPD and Asthma Remains USP

Post author By administrator
Post date August 10, 2021
No Comments on Smart Pulse Oximeters Market: Awareness Drives for Treatment of COPD and Asthma Remains USP

Continuous technological advancements and introduction of efficient pulse oximeters are the key driving factors for pulse oximeters market growth. The global sales of pulse oximeters were estimated at US$ 1.2 Bn in 2019, and projected to witness moderate growth during the forecast period (2019 – 2029).

“Technological advancements leading to the introduction of new and advanced products and emergence of number of players in the market have intensified pulse oximeter sales,” says a Fact.MR analyst.

In January 2017, Masimo launched two patient monitoring products in India namely, Rad-97 Pulse-CO Oximeter and SedLine Brain Function Monitoring. These products are expected to improve the patient monitoring capabilities of clinicians. Moreover, government-driven price management and reimbursement controls, particularly in China and Japan, are offering significant opportunities for manufacturers to invest in these regions. Increasing government initiatives to spread awareness related to various respiratory diseases are boosting the sales of pulse oximeter devices.

For detailed insights on enhancing your product footprint, request a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4449

Key Takeaways of Pulse Oximeter Market Study

A large number of companies manufacturing handheld pulse oximeters significantly contributed to the market share in terms of revenue in the pulse oximeters market.
North America and Europe collectively hold over 60% of the pulse oximeters market share owing to rapid new product launches in these regions.
In terms of end user, hospitals are expected to dominate the pulse oximeters market during the forecast period.
The pulse oximeter market is highly fragmented. Some of the prominent manufacturers include Masimo Corp, Medtronic plc., Koninklijke Philips NV, GE Healthcare, Rossmax International Ltd. and few others.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4449

Key Segments of Pulse oximeters Market

Fact.MR’s study on the pulse oximeters market offers information divided into three important segments – product type, end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type	Finger Pulse Oximeters Hand Held Pulse Oximeters Table Top Pulse Oximeters Wrist Pulse Oximeters
End User	Hospitals Clinics Ambulatory Surgical Centres Homecare Settings
Region	North America Latin America Europe South Asia East Asia Oceania Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4449

Awareness Drives for Treatment of COPD and Asthma Remains USP

Several awareness programs have been introduced and promoted by various health organizations or healthcare societies such as online education programs for healthcare professionals, medication maintenance programs and environmental programs, across the globe to control respiratory disorders such as asthma, COPD and other respiratory disease. The introduction and promotion of various awareness programs are expected to increase the growth of pulse oximeters market. These government programs encourage people to adopt early medication, which is expected to increase the revenue generation for the global pulse oximeters market in the forecast years.

pulse oximeters market 2

Looking for More Information?

The research study on pulse oximeter market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of pulse oximeter over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of product type (finger pulse oximeters, hand held pulse oximeters, table top pulse oximeters and wrist pulse oximeter), and end user (hospitals, clinics, ambulatory surgical centers and homecare settings) across seven major regions.

Get More Insights
https://www.biospace.com/article/thermasonic-ultrasound-gel-warmers-demand-propelled-by-expansion-of-3d-and-doppler-ultrasound-says-fact-mr/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Tags Pulse Oximeters Market, Pulse Oximeters Market report, smart Pulse Oximeters Market, table top Pulse Oximeters Market, wrist Pulse Oximeters Market

Pharmaceutical

Increase In R&D Spending In The Pharmaceutical Industry Opens Up The New Avenues for Cytokines Drugs : Report Fact.MR

Post author By administrator
Post date August 10, 2021
No Comments on Increase In R&D Spending In The Pharmaceutical Industry Opens Up The New Avenues for Cytokines Drugs : Report Fact.MR

Self-administered drugs through pre-filled syringes offer opportunities to reduce consumer spending on caregiver fees. Furthermore, manufacturers are gaining sharper profit margins with the introduction of this drug delivery medium in their portfolio. On this backdrop, the global demand for parenteral drugs was estimated at US$ 451 Bn in 2019, is projected to witness moderate growth during the forecast period (2019 – 2029). Parenteral drug manufactures are currently focused on maintaining high quality of their products.

For detailed insights on enhancing your product footprint, request for a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=3189

Drugs for cancer are always short in supply in countries where the market is monopolistic and access to such medicines is dominated by a single player. Rising prevalence of chronic illnesses such as cancer, cardiovascular diseases, and diabetes, across the globe has been the prime revenue driver for parenteral drugs and this trend is not likely to abate any time in the foreseeable future.

Key Takeaways of Parenteral Drugs Market Study

By product type, monoclonal antibodies segment accounts for maximum market share in terms of revenue in the parenteral drugs market. This is primarily attributed to the rising adoption of biologics and subsequent rise in the number of biologics approved for marketing.
North America and Europe collectively hold over 60% of the parenteral drugs market share owing to the rise in new product launches in the regions.
Hospital pharmacies segment is expected to be the dominant distribution channel in the parenteral drugs market.
The parenteral drugs market is highly fragmented. Some of the prominent parenteral drug manufacturers include, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis AG, and Pfizer Inc., among many others.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=3189

“Patent expiration of branded products and fewer new product launches have resulted in the rise of generic versions of drugs, and in the emergence of a number of players in the market – this factor has intensified total parenteral drugs sales,” says a Fact.MR analyst.

parenteral drugs market 03

Key Segments of Parenteral Drugs Market

Fact.MR’s study on the parenteral drugs market offers information divided into six important segments— product type, application, molecule type, route of administration, distribution channel, and region.

This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type	Monoclonal Antibodies Immunoglobulin Cytokines Insulin Peptide Hormones Blood Factors Peptide Antibiotics Vaccines Small Molecule Antibiotics Chemotherapy Agents Others
Application	Oncology Infectious Diseases Diabetes Blood disorders Hormonal Disorders Musculoskeletal Disorders CNS Diseases Pain Management Cardiovascular Diseases
Molecule Type	Small Molecules Large Molecules
Route of Administration	Intravenous (IV) Intramuscular (IM) Subcutaneous (SC)
Distribution Channel	Hospital Pharmacies Retail Pharmacies Drug Stores Online Pharmacies
Region	North America Latin America Europe South Asia East Asia Oceania Middle East & Africa

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/3189

Increased Research Funding to Drive Parenteral Drugs Market Growth

Research funding has surged significantly in recent years, which has resulted in an increase in the number of projects undertaken as well as newly employed personnel for the same. The funding for research comes from governments, private players, and other commercial entities. For instance,

In 2017, the National Cancer Institute (NCI) received over US$ 5.6 billion for research initiatives, which reflects a 7% increase as compared to 2016.
Similarly, in 2018, in the U.S., the Omnibus Appropriations bill that provided additional funding of US$ 3 billion for the NIH (National Institutes of Health) was passed, which is the highest increase in NIH funding in the past 15 years. This boost in funding, which brings the total NIH investment to US$ 37.1 billion for FY 2018, is expected to speed up cancer research in the coming years.
The expected trend indicates a significant rise in NIH funding in the fiscal year 2017 – 2018. In the future, investments in R&D are likely to increase in all countries across the world, especially in countries such as China and Brazil.

For More Insights
https://www.biospace.com/article/canine-influenza-treatment-demand-driven-by-high-unmet-requirement-for-treatment-of-canine-flu-says-fact-mr

Looking for More Information?

The research study on parenteral drugs market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of parenteral drugs over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of product type (monoclonal antibodies, immunoglobulin, cytokines, indulin, peptide harmones, blood factors, peptide antibiotics, vaccines, small molecule antibiotics, chemotherapy agents, and others), application (oncology, infectious diseases, diabetes, hormonal disorders, musculoskeletal disorders, CNS diseases, pain management and cardiovascular diseases), route of administration (intravenous, intramuscular and subcutaneous), and distribution channel (hospital pharmacies, retail pharmacies, drug stores and online pharmacies) across seven major regions.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Tags Cytokines drugs market, Immunoglobulin drugs market, insulin drugs market, Parenteral Drugs Market, parenteral drugs market forecast

Pharmaceutical

Sales of Alprazolam Medicine Is Expected to Record a CAGR of Around 2.7% Over the Forcast Period

Post author By administrator
Post date August 10, 2021
No Comments on Sales of Alprazolam Medicine Is Expected to Record a CAGR of Around 2.7% Over the Forcast Period

The demand for benzodiazepine drugs is expected to record a pedestrian CAGR of around 2.7% during the forecast period (2020-2026). The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing prevalence of anxiety in parallel with rising awareness regarding benzodiazepine drugs is reflecting on increasing opportunities for players in the U.S. market. As per a report by the Anxiety and Depression Association of America (ADAA), each year, over 40 Mn adults in the U.S. suffer from anxiety disorders.

A comprehensive study by Fact.MR opines that demand for benzodiazepine drugs would remain high-albeit generic ones-which would drive voluminous sales, though contribute moderately to market value.

For detailed insights on enhancing your product footprint, request for a sample here-

https://www.factmr.com/connectus/sample?flag=S&rep_id=4432

Presence of a large number of hospital and retail pharmacies further makes it easy for individuals to purchase benzodiazepine drugs. A significant influence of high concentration of leading players is also auguring well for the U.S. benzodiazepine drugs market, which has been discussed in detail, in a recent Fact.MR study.

A subject matter expert at Fact.MR opines, “Regulations regarding development of benzodiazepine drugs are relatively stringent in developed regions such as North America and Europe, which opens ground for branded as well as generic drugs in developing regions. As a result, entry barriers in developed regions would be high, while those in developing regions would be moderate.”

analysis of benzodiazepine drugs market by application

Key Highlights of Benzodiazepine Drugs Market Study

Easy accessibility is a key feature driving substantial sales of benzodiazepine drugs through retail pharmacies. By 2026, these pharmacies are projected to record value tantamount to US$ 1.4 Bn. Additionally, sales prospects for benzodiazepine drugs are likely to grow during the forecast period, as consumers are evincing high interest in online pharmacies.
Popularity of short-acting benzodiazepine drugs is expected to increase during the forecast period, as these induce less hangover effect and take relatively short time of action. On the back of this, around 77% of the total share would be attributable to the sales of short-acting benzodiazepine drugs.
Being a highly prevalent disorder among individuals leading a demanding lifestyle, anxiety is projected to account for a sizeable share tantamount to around 53% in the benzodiazepine drugs market during the forecast period.
Reduction in the number of prescriptions for benzodiazepine drugs, especially in countries such as the U.S., the U.K., and Canada, would impede market growth during the forecast period.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4432

Benzodiazepine Drugs Market – Assessment of Key Segments

Distribution Channel	Hospital Pharmacies Retail Pharmacies Others
Time of Action	Ultra-short Acting Short Acting Long Acting
Application	Anxiety Seizures Insomnia Alcohol Withdrawal Others
Product	Alprazolam Clonazepam Diazepam Lorazepam Others
Region	North America Europe Asia Pacific Latin America Middle East & Africa

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4432

High Popularity of Generic Drugs Puts Pressure on Branded Products of Leading Players

The benzodiazepine drugs market features fragmentation, as leading players operate under the constant pressure of patent expiration of branded products. High investments made towards the development of innovative and new products by leading players intensifies pressure to achieve the desired RoI. For instance, in 2017, F.Hoffmann-La Roche AG invested around one-fifth of the total revenue to strengthen the pipeline of innovative products. Stringent regulations on innovative drugs further make it difficult for leading players to gain desired marketability.

On the other side, the focus of prominent and leading players is on achieving better penetration into the benzodiazepine drugs market through the development of generic drugs. Growing sales of generic benzodiazepine drugs are putting pressure on leading players to squeeze their profit margins and adopt a cost-competitive strategy to have better sales prospects.

Find More Valuable Insights on Benzodiazepine Drugs Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global benzodiazepine drugs market, presenting historical demand data (2016-2019), and forecast statistics for the period of 2020-2026. The study divulges compelling insights on the benzodiazepine drugs market on the basis of distribution channel (hospital pharmacies, retail pharmacies, and others), time of action (ultra-short acting, short acting, and long acting), application (anxiety, seizures, insomnia, alcohol withdrawal, and others), and product (alprazolam, clonazepam, diazepam, lorazepam, and others), across five major regions.

For More Insights
https://www.biospace.com/article/with-growing-number-of-pet-parents-and-care-awareness-heartworm-treatment-market-is-witnessing-promising-growth/

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1212/benzodiazepine-drugs-demand

Tags Alprazolam medicine market, Benzodiazepine Drugs Market, Benzodiazepine medicine Market, Clonazepam medicine market, Diazepam medicine market

Pharmaceutical

North America Imipenem Based Antibiotics Is Expected to Offer Substantial Revenue Generation Opportunities Says Fact.MR

Post author By administrator
Post date August 10, 2021
No Comments on North America Imipenem Based Antibiotics Is Expected to Offer Substantial Revenue Generation Opportunities Says Fact.MR

Incidence of bacterial infections with multidrug resistance is increasing rapidly, generating the need for novel, broad-spectrum carbapenem-based antibiotics for the treatment of various bacterial infections. Broad-spectrum carbapenem-based antibiotics such as tebipenem (Spero Therapeutics Inc.) and sulopenem (Iterum Therapeutics Inc.) are at late stage clinical development with expected launch of both in 2020 – 2021. Incidence of bacterial infections is increasing rapidly across the world offering significant revenue generating opportunities for the carbapenem-based antibiotics market.

Multidrug resistance to currently marketed carbapenem-based antibiotics is largely prevalent in the world. Also, expiry of patent for ertapenem is expected to offer new avenues for market growth in regulated as well as non-regulated carbapenem-based antibiotics market where its adoption & availability are comparatively limited. On the back of these factors, the global sales of carbapenem-based antibiotics is estimated to reach a valuation of US$1.8 Bn by 2029.

For detailed insights on enhancing your product footprint, request for a sample here-

https://www.factmr.com/connectus/sample?flag=S&rep_id=4425

“ Recently, FDA granted Qualified Infectious Disease Product (QIDP) to sulopenem as well as tebipenem for new indications, which is further expected to broaden the growth prospect of the carbapenem-based antibiotics market,” says the Fact.MR Analyst.

Key Takeaways of Carbapenem-based Antibiotics Market Study

Larger patient pools and launch of novel products for the treatment of bacterial infections are expected to shape the carbapenem-based antibiotics market landscape.
Increasing prevalence of bacterial infections caused by longer stay in hospitals as well as immunocompromising chronic diseases that make patients prone to bacterial infections is expected to boost carbapenem-based antibiotics market growth.
Currently, the carbapenem-based antibiotics market is dominated by ertapenem. However, tebipenem is expected to gain traction during the forecast period in terms of revenue.
In terms of indication, pneumonia is expected to garner highest market share as compared to other bacterial infections owing to a large patient pool.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4425]

Fact.MR’s study on the carbapenem-based antibiotics therapy market offers information divided into four important segments – product, indication, sales channel, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.

Key Segments of Carbapenem-based Antibiotics Market

Product Type	Meropenem Ertapenem Imipenem Doripenem Panipenem Tebipenem
Indication	Intra-abdominal Infections Urinary Tract Infections Pneumonia Bacterial Meningitis Skin and Skin Structure Infections Acute Pelvic Infections Prophylaxis of Surgical Site Infection Respiratory Tract Infections Gynaecologic Infections Endocarditis Others
Sales Channel	Hospital Pharmacies Retail Pharmacies & Drug Stores Online Pharmacies
Region	North America Latin America Europe South Asia East Asia Oceania Middle East & Africa

Strategic Expansion by Dominant Players Benefiting Market

The carbapenem-based antibiotics market is dominated by top three players including Merck Co. & Inc., Pfizer Inc., and Sumitomo Dainippon Pharma Co., Ltd. These leading players in the carbapenem-based antibiotics market contribute around 80% to 90% revenue share. Clinical stage companies such as Spero Therapeutic Inc. and Iterum Therapeutics Inc. with the launch of their novel carbapenem-based antibiotics are expected to acquire significant market space. In October 2017, Spero Therapeutics, Inc. and Meiji Seika Pharma Co., Ltd. announced an exclusive licensed partnership for its carbapenem-based antibiotic named SPR994 (tebipenem). In a similar development, Sumitomo Dainippon Pharma in June 2017, announced a partnership with Zuellig Pharma for sales of carbapenem-based antibiotic meropenem in five countries of Southeast Asia (Vietnam, Thailand, Singapore, Philippines, Malaysia) and Hong Kong.

Full Access of this Exclusive Report is Available at-
https://www.factmr.com/checkout/4425

carbapenem based antibiotics market 01

Key Questions Answered in Fact.MR’s Carbapenem-based Antibiotics Market Report

Which regions will continue to remain the most profitable regional markets for carbapenem-based antibiotics market players?
Which factors will essentially induce a change in the demand for carbapenem-based antibiotics in the forecast period?
How will changing trends impact the carbapenem-based antibiotics market?
What are key manufacturers’ strategy to enhance their product adoption and improve regional product footprints?
Which companies are leading the carbapenem-based antibiotics market?

For More Insights
https://www.biospace.com/article/epidermal-cell-sheets-sales-surges-due-to-growing-need-for-effective-and-safe-guiding-technology-says-fact-mr/

Looking for more information?

The research study on carbapenem-based antibiotics market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends which have shaped the landscape of carbapenem-based antibiotics over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence over 2019 – 2029. Market statistics have been presented on the basis of product type (Meropenem, imipenem, ertapenem, tebipenem, doripenem, panipenem, etc.), indication (intra-abdominal infections, urinary tract infections, pneumonia, bacterial meningitis, skin and skin structure infections, acute pelvic infections, prophylaxis of surgical site infection, respiratory tract infections, others), sales channel (hospital pharmacies, retail pharmacies, online pharmacies) across seven major regions.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Tags Carbapenem-based Antibiotics Market, Carbapenem-based Antibiotics Market report, Carbapenem-based Antibiotics Market size, Carbapenem-based Antibiotics Market trends

Pharmaceutical

Medical Gases and Equipment Market to See Huge Growth by 2026 | Companies Airgas Inc., Atlas Copco AB, GCE Group AB and Praxair Inc.

The global demand of medical gases and equipment market is exhibiting steady growth with the surge in demand from hospitals, home care settings, pharmaceutical companies, and other healthcare facilities. A recent study by Fact.MR states that the medical gases and equipment market is anticipated to grow at over 8% CAGR during the forecast period between 2020 and 2030.

Rising cases of chronic ailments such as diabetes, cancer, asthma, cardiovascular and respiratory diseases, and communicable diseases have been creating scope for expansion. According to the Centers for Disease Control and Prevention, one out of two adults in the U.S. suffer from chronic diseases.

Request a report sample to gain compressive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5428

Data obtained from same source revealed that 86% of national expenditure, accounting for US$ 2.7 trillion, were incurred on the treatment of mental health conditions and chronic ailments in the U.S. These facts and figures indicate the surge in incidence of chronic ailments, which is expected to fuel the demand for medical gases and equipment in the coming years.

Though the outbreak of COVID-19 pandemic has impacted production process across manufacturing units in the first half of this year, the market is forecast to recover soon owing to the rush of patients across healthcare facilities.

Key Takeaways from Medical Gases and Equipment Market Report

The increase in therapeutic application of medical gases and equipment is forecast to fuel the sales through the forecast period
Hospitals will continue exhibiting surging demand in the coming years
North America will dominate in the global medical gases and equipment market, with the U.S at the forefront. The demand from East Asia too is expected to rise in the coming years
With the on-set of COVID-19 pandemic, the market has been experiencing surge in demand which tends to persist over the next couple of years

“The therapeutic application of medical gases and equipment has risen significantly over the past decade. Due to having diverse advantages such as effective to treat burn, strokes, providing hypoxia therapy in children, and others, the demand for therapeutic medical gases is projected to rise in the coming years,”said a Fact.MR analyst

Surge in Demand for Medical Gases Propelling Growth

Medical gases and equipment are used extensively in medical processes such as anesthesia, intensive care treatment, respiratory therapy, and others. Various types of medical gases such as oxygen, nitrous oxide, helium, carbon dioxide, and others are used in medical gas supply systems in hospitals and other healthcare facilities.

With the rapid expansion of healthcare industry, the demand for medical gases is sky-rocketing which is catering to the growth of the market. According to India Brand Equity Foundation (IBEF), the hospital industry in India is growing at a steady pace and is likely to reach at US$ 132.84 billion by fiscal year 2022. This indicates surging prospects for sales across high potential markets.

Furthermore, the rapid growth of pharmaceutical and biotechnology industry is fuelling the demand for medical gases, which in turn is enabling growth in the market.

Request More Information about Report Methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5428

Medical Gases and Equipment Market: Competitive Landscape

In order to sustain in the positions amid increasing competition, market players in the medical gases and equipment market are emphasizing on launching of broader categories of products.

For instance,

Airgas Inc. launched its new range of medical-grade gases which are highly efficient in managing medical-grade oxygen, medical-grade liquid nitrogen, and others for various applications such as respiratory therapy, burn therapy, and others in the recent year
Praxair Inc. launched its new extensive range of medical gases such as trigas which is a mixture of Oxygen, Nitrogen, and Carbon Dioxide and used in In Vitro Fertilization machines, synthetic air for ICU, PICU, and NICU areas, and others in the current year

Some of the companies profiled in the medical gases and equipment market report are Airgas Inc., Atlas Copco AB, GCE Group AB, Matheson Tri-Gas Inc., Messer Group GmbH, and Praxair Inc.

More Valuable Insights on Medical Gases and Equipment Market

In its latest report, Fact.MR has provided detailed analysis on the global medical gases and equipment market, comprising data on historical statistics (2015-2019) and forecasts of demand for the period of 2020 to 2030. The report discusses critical insights on the medical gases and equipment market in terms of product (medical gases (pure medical gases, oxygen, carbon dioxide, nitrous oxide, and helium), medical gas mixtures (blood gas mixtures, lung diffusion mixtures, nitrous oxide-oxygen mixtures, carbon dioxide-oxygen mixtures, laser-gas mixtures, aerobic gas mixtures, anoerobic gas mixtures, ethylene oxide/sterilant gas mixtures, and helium-oxygen mixtures), medical gas equipment (gas delivery systems, cryogenic products (freezers), equipment accessories (vacuum systems, manifolds, regulators, flowmeters, hoses, valves with integrated pressure regulators (VIPRS), medical air compressors, and others))), application (therapeutic, pharmaceutical manufacturing & research, diagnostic, and other applications), end user (hospitals, home care settings, pharmaceutical & biotechnology companies, academic & research institutes, and emergency services), across 5 key regions (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).

Get More Insights- https://www.prnewswire.com/news-releases/versatility-of-traditional-chinese-medicines-make-it-highly-sought-after-in-skincare-fact-mr-301288790.html

Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

Explore Fact. MR’s Coverage on Healthcare Domain

Skincare serum market: The global skincare serum market report published by Fact.MR offers an exhaustive analysis on the prominent growth dynamics, including possible drivers, opportunities and challenges, expected to prevail across the landscape for the upcoming decade. A detailed insight regarding key geographies and prominent manufacturers has been embedded in this report.

OTC herbal and traditional medicine Market: Fact. MR’s latest report on global OTC herbal and traditional medicine market gives a detailed insight on the key drivers, trends and opportunities expected to prevail across prominent segments and key geographies for the forthcoming assessment period. Additionally, details about prominent manufacturers and their revenue shares have also been incorporated.

Geriatric medicine Market: The latest report by Fact.MR on global geriatric medicine market offers an unbiased analysis on the growth prospects, strategies and competitive landscape for the upcoming period. The key players’ market share data provided by the report given you detailed insights on the shortcomings and forthcomings of the market for the forecast period.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/5428/medical-gases-and-equipment-market
Press Release: https://www.factmr.com/media-release/1768/global-medical-gases-and-equipment-market

Tags Medical Gases and Equipment Market, Medical Gases and Equipment Market forecast, Medical Gases and Equipment Market insights, Medical Gases and Equipment Market report, Medical Gases and Equipment Market size

Pharmaceutical

Respiratory Virus Vaccines Market 2030: Industry Growth with Key Manufacturers Analysis| Top Players Bharat Biotech, CSL Limited, AstraZeneca, Sanofi, GlaxoSmithKline plc.

Incessantly rising demand in response to the unbridled spread of COVID-19 has pushed the growth of respiratory virus vaccines market to the fore. Fact MR’s recent study on the market is intended to offer insights into the future and discover hidden opportunities for market players. Increasing R&D investments and initiatives are aiding exponential growth in the market.

Considering that the aforementioned trend will show no signs of slowing down, Fact.MR projects the market to rise at an 8% CAGR from 2020 and 2030. With some prominent international organizations increasing their funding towards research & development, the market is expected to gain significant impetus over the coming years. For instance, the National Institute of Allergy and Infectious Diseases (NIAID) has recently announced a funding of US$ 51 Mn towards the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program, with the intention of developing influenza vaccines.

Request a report sample to gain compressive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=5199

Key Takeaways from Respiratory Virus Vaccines Market Study

The global respiratory virus vaccines market is expected to surpass a valuation of US$ 14 Bn by 2030.
North America currently dominates the global market for respiratory virus vaccines.
Based on type, inactivated/ killed vaccines’ hegemony will continue through 2030.
Based on indication, demand from the influenza segment will remain comparatively higher.
Among all the age groups, demand from the pediatric segment is likely to be higher.
Physician offices are currently dominating among the end users.

“Demand witnessed in the respiratory virus vaccines market is forecast to surge especially on account of the unprecedented outbreak of COVID-19. An increasing number of market players are expected to focus on research initiatives, to gain a competitive advantage in this space,” says a Fact.MR analyst.

respiratory virus vaccines market competitive analysis

Rising Burden of Respiratory Illnesses Fuelling Demand

According to the World Health Organization, nearly 290,000 to 650,000 people die every year around the world due to flu-related illnesses. Rising incidence of respiratory illnesses and subsequently increasing demand for vaccines to prevent respiratory infections are the chief drivers of the global market.

Request More Information about Report Methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5199

With leading pharmaceutical companies racing to be the first to develop and launch a vaccine for the novel coronavirus, the respiratory virus vaccines market is expected to surge exponentially through the course of the forecast period.

Government Initiatives to Make Vaccines Better Accessible

Governments around the world are adopting various initiatives to curb incidence of chronic ailments. They are also funding researches on vaccination programs and overall expansion of the healthcare sector, which is expected to enable growth in the market.

For instance, in April 2017, the Government of Canada announced its plans of investing C$ 1.7 Mn in the Immunization Partnership Fund. Through this, it intended to fund various projects on improving vaccination coverage across Canada.

Respiratory Virus Vaccines Market Insights by Indication

Based on indication, the global market can be classified into mumps & rubella, measles, influenza, coronavirus disease (COVID-19), and others. Of these, the influenza segment currently holds prominence. Rising cases of influenza around the world have made effective vaccination programs highly necessary for children.

Over the coming years, the market will witness rising demand from the COVID-19 segment. In the absence of proper vaccination, governments around the world are leaving no stone unturned to discover a potential cure.

None of them are holding back from investing in research & development (R&D) towards finding a vaccine for the disease. Spurred by the impetus from various governments and healthcare organizations, this category has the potential of skyrocketing over the coming years.

Get More Insights- https://www.biospace.com/article/ngs-sample-preparation-market-surging-at-16-percent-cagr-rising-demand-for-effective-treatment-of-chronic-diseases-driving-growth-fact-mr-study-/

More Valuable Insights on Respiratory Virus Vaccines Market

Fact.MR, in its new offering, presents an unbiased analysis of the global respiratory virus vaccines market, presenting historical demand data (2015-2019) and forecast statistics for the period of 2020-2030. The study divulges essential insights on the respiratory virus vaccines market on the basis of type (inactivated/killed vaccines, live-attenuated vaccines, and recombinant vaccines), route of administration (intramuscular, intranasal, and subcutaneous), indication (influenza, measles, mumps & rubella, and COVID-19), age group (adults and pediatric), and end user (physician offices, hospitals, clinics, and pharmacies/ stores), across major regions of the world (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/5199/respiratory-virus-vaccines-market
Press Release: https://www.factmr.com/media-release/1683/global-respiratory-virus-vaccines-market

Tags Respiratory Virus Vaccines Market, Respiratory Virus Vaccines Market forecast, Respiratory Virus Vaccines Market report, Respiratory Virus Vaccines Market size, Respiratory Virus Vaccines Market trends

Pharmaceutical

NGS Sample Preparation Market is expected to be valued at over US$ 4 billion by 2031

Post author By administrator
Post date August 10, 2021
No Comments on NGS Sample Preparation Market is expected to be valued at over US$ 4 billion by 2031

The global NGS sample preparation market is expected to surpass a valuation of US$ 4 billion by 2031, expanding at a whopping CAGR of approximately 16% across the 2021-2031 forecast period, according to a recent report published on the market by award-winning consulting firm Fact.MR. Next generation sequencing (NGS) has revolutionized genomic research, paving the way for highly effective diagnosis of numerous chronic and infectious diseases, a fact that is boding well for market growth.

Historically, the market accrued significant gains, surpassing US$ 750 million in value in 2019. In recent years, NGS has been widely deployed in clinical oncology to advance personalized cancer treatment. The technique has proven useful in identifying novel and rare cancer mutations, detecting familial cancer mutation carriers, and providing molecular rationale for appropriate targeted therapy.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=5932

In recent years, NGS sample preparation market gained growth due to advancements in clinical oncology to offer effective cancer treatment. NGS sample preparation technique has proved effective approach in identifying novel and rare cancer mutations and in detecting familial cancer mutation carriers. Thus, increasing prevalence of the diseases will boost the demand for NGS sample preparation.

Key Takeaways from Market Study

High demand for NGS sample preparation kits, reagents, and consumables
By application, NGS sample preparation for drug & biomarker discovery poised to reach higher echelons
Academic and research institutes to remain primary NGS sample preparation end users
Presence of robust healthcare system to pivot NGS sample preparation product sales across the U.S.
India to extensively deploy NGS sample preparation products to augment prenatal screening

“Prominent NGS sample preparation product manufacturers are testing uncharted waters by foraying into domains such as animal and plant health, to develop highly advanced diagnostic approaches and address multiple ailments, widening expansion prospects,”

comments a Fact.MR analyst.

Request More Information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5932

Competitive landscape:

Key players in NGS Sample Preparation Market are adopting various strategies to increase their revenue share. For instance:

In April 2021, QIAGEN N.V introduced the QIAseq DIRECT SARS-CoV-2 Kit, a viral genome enrichment and library preparation solution to reduce library turnaround times and plastics use for NGS.
Thermo Fisher Scientific approved a definitive agreement to acquire PPD Inc. at a purchase price of US$ 17.4 billion to enhance innovation and development in drug productivity.
In May 2021, Integrated DNA Technologies (IDT) Inc. collaborated with Swift Biosciences to augment its NGS library preparation genomics kits for academic, translational and clinical research.

Other key players operating in market are Merck KGaA (Merck Millipore), F. Hoffmann-La Roche Ltd, Agilent Technologies, Promega Corporation, Illumina Inc, Integrated DNA Technologies Inc. (Danaher Corporation), New England Biolabs, and Tecan Trading AGing.

More Insights on the Global NGS Sample Preparation Market:

Fact MR, in its new offering, brings to fore an unbiased analysis and global industry analysis of the global NGS sample preparation market, presenting historical demand data (2016-2020) and forecast statistics for the period (2021-2031). The study divulges compelling insights on the NGS sample preparation market with detailed segmentation based on product type (NGS sample preparation instruments, sample preparation kits, reagents, and consumables), based on application (NGS sample preparation for drug and biomarker discovery, sample preparation for diagnostics sample preparation for precision medicines, and others as agriculture and animal research), based on end users (hospitals and diagnostic centers, biotechnology, pharmaceutical , and academic and research institutes)

Explore Fact.MR’s Coverage on the Healthcare Domain

NGS Data Analysis Market: A new report of Fact.MR envisages the global market for NGS data analysis to record a spectacular growth during the forecast period (2017-2026).

Oncology Small Molecule Drugs Market: Fact.MR’s “Oncology Small Molecule Drugs Market – Global Market Insights 2019-2029,” provides a detailed analysis on the global oncology small molecule drugs market. Size of the oncology small molecule drugs market has been analyzed in a comprehensive way and is presented in terms of value (US$ Mn).

Glaucoma Diagnostics Market: The global Glaucoma Diagnostics market is anticipated to show significant growth as Optical Coherence Tomography (OCT) Imaging Systems, Corneal Pachymeters, Tonometers offers greater advantage over tradition procedures for diagnosis of glaucoma.

About Fact.MR

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/ngs-sample-preparation-market
Press Release: https://www.factmr.com/media-release/1992/global-ngs-sample-preparation-market

Tags demand of NGS based testing, demand of NGS sample preparation products, demand of NGS screening, global NGS sample preparation market, next generation sequencing (NGS) sample preparation market, next generation sequencing sample preparation market, NGS for drug & biomarker discovery, NGS library preparation kits, NGS sample preparation for diagnostics, NGS sample preparation instruments demand, NGS sample preparation kits, NGS sample preparation market, NGS Sample Preparation Product Manufacturers, NGS sample preparation products, NGS-based in vitro diagnostic solutions, reagents & consumables, sales of NGS sample preparation products

Pharmaceutical

Growing Number Of Millennial Pet Owners Will Provide Push To Global Canine Parvovirus Market Sales, Fact.MR Study

Post author By administrator
Post date August 9, 2021
No Comments on Growing Number Of Millennial Pet Owners Will Provide Push To Global Canine Parvovirus Market Sales, Fact.MR Study

FACT.MR is highly equipped with professionals who put extra efforts in meeting the requirements of the clients. Since its inception, FACT.MR has been keeping a constant eye on the ongoing trends and events across diverse industries and regions. With space-age industrial tools, our analysts perform an extensive research (Both primary and secondary) to facilitate clients with up-to-date Canine Parvovirus Market information. Client satisfaction is our top priority, hence we create reports strictly sticking to the requisites of the clients. The objective of the report is to highlight the factor affecting the demand and sales of the Canine Parvovirus across the healthcare industry.

The extended periods of lockdowns and restriction on movements due to COVID-19 pandemic can affect the accessibility of veterinary hospitalization which is required in canine parvovirus infection cases. This could delay the diagnosis and treatment of the canine parvovirus condition thereby impacting the global canine parvovirus treatment market.

Request a Report Sample to gain comprehensive Market Insights at: https://www.factmr.com/connectus/sample?flag=B&rep_id=5196

Canine Parvovirus Market: Drivers and Restraints
The major driver for the global canine parvovirus market would the growing pet owners worldwide which is evident from the fact that the number of pet owners has more than tripled in the USA from 1970s. The increasing income disposability of people coupled with their willingness to invest in pet care can be yet another driver for the global canine parvovirus market. The shift in the way pets are cared for and growing number of millennial pet owners can also provide push to the global canine parvovirus market. The major barrier in the development of the global canine parvovirus market could be the general unawareness among the pet owners about the canine parvovirus in the developing countries.

Canine Parvovirus Market: Segmentation The global canine parvovirus market is segmented based on the drug class, route of administration, distribution channel and region.

By drug class, the global canine parvovirus treatment market is segmented as:

Antibiotics
Antiemetics
Intravenous (IV) Fluids
Others

By route of administration, the global canine parvovirus treatment market is segmented as:

Intravenous
Oral

By distribution channel type, the global canine parvovirus market is segmented as:

Hospital Pharmacies
Online Pet Drugs Stores
Veterinary Drugs Stores

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=5196

Canine Parvovirus Market: Key Players
The major players operating in the global canine parvovirus market are Merck Animal Health, Zoetis United States, Amber Naturalz, Merial (Sanofi), MSD Animal Health, Durvet, Elanco among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

A few focus points of this Research are given below:

Give a deep-dive analysis of the key operational strategies with a focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies
Provide an overview of the product portfolio, including product planning, development, and positioning -Discuss the role of technology companies in partnerships
Explore the regional sales activities
Analyze the Canine Parvovirus market size and giving the forecast for current and future Contraceptives Market during the forecast 2020 to 2030
Analyze the competitive factors, competitors’ Canine Parvovirus market shares, product capabilities, and Canine Parvovirus Market supply chain structures.
In-depth analysis of various Canine Parvovirus Market insights, namely, Canine Parvovirus Market trends, growth drivers, opportunities, and other related challenges.
The potency of suppliers and buyers to make better business decisions.
The report provides a comprehensive analysis of key factors that are expected to drive the Demand of Canine Parvovirus market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Sales of Canine Parvovirus market.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Prepackaged Medical Kits and Trays Market: Proliferation of multi-specialty hospitals across the world is a major reason for the ever-increasing demand for prepackaged medical kits and trays across regions. Demand is high for prepackaged disposable medical products, especially with the onset of contagious diseases such as COVID-19.

Cables and Leads for Medical Equipment Market: Fact.MR’s cables and leads for medical equipment industry analysis shows that the global market was valued at US$ 4.5 Bn in 2020, and is projected to top US$ 6 Bn by 2031, expanding at a CAGR of 4%. Demand for ECG equipment is projected to reach a valuation of US$ 2.7 Bn by 2031.

Coatings for Medical Devices Market: The coatings for medical devices market will continue exhibiting positive rate of growth between 2020 and 2030. Despite hindrances witnessed during COVID-19 due to supply-chain disruptions and restricted transport, sales will continue surging on the back of mushrooming healthcare facilities.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Tags Canine Parvovirus Market, Canine Parvovirus Market Future Growth, Canine Parvovirus Market insight, Canine Parvovirus Market Segmentation, Canine Parvovirus Market Share, Canine Parvovirus Market size, Canine Parvovirus Market trends

Pharmaceutical

Influence Of Yoga And Alternative Therapies Is Generating Large Demand For Pulsed Electromagnetic Field Therapy Devices Market

The study on the Pulsed Electromagnetic Field Therapy Devices Market Research offers a profound comprehension of the market dynamics like opportunities, drivers, trends, and the challenges. The analysis further elaborates on the micro and macro-economic aspects which can be predicted to shape the rise of the Pulsed Electromagnetic Field Therapy Devices Market throughout the forecast period (2021-2031). The objective of the report is to highlight the factor affecting the demand and sales of the Pulsed Electromagnetic Field Therapy Devices across the healthcare industry.

Pulsed Electromagnetic Field Therapy Devices Market: Segmentation
To gain a comprehensive and a better understanding of the future market equity, the pulsed electromagnetic field therapy devices report is segmented by power, waveform, end user, distribution channel and region.

Request a Sample Report containing crucial Graphs and Figures – https://www.factmr.com/connectus/sample?flag=S&rep_id=2561

Based on power, the global smart asthma management devices market is segmented into the following:

Low-Powered Devices
High-Powered Therapy Devices

Based on waveform, the global pulsed electromagnetic field therapy devices market is segmented into:

Square
Saw Tooth
Sine
Trapezoidal

Based on end user, the global pulsed electromagnetic field therapy devices market is segmented into:

Hospitals
Wellness Clinics
Home Care Settings

Based on distribution channel, the global pulsed electromagnetic field therapy devices market is segmented into:

Online Stores
Retail Stores

The Report aims to resolve the subsequent doubts regarding the Pulsed Electromagnetic Field Therapy Devices Economy:

What Would be the trends that are dictating the development of the Pulsed Electromagnetic Field Therapy Devices Market?
What Is your reach of innovation in the current Pulsed Electromagnetic Field Therapy Devices Market landscape?
How Will the recent amendments in the industrial coverages in place 1 and region 2 affect the development of the market?
What Is the value of the Pulsed Electromagnetic Field Therapy Devices Market in 2029?
That Regional market is predicted to witness the highest CAGR increase during the assessment period?

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2561

The analysis also sheds light on the impact of various government initiatives undertaken across the globe on the Pulsed Electromagnetic Field Therapy Devices Market. Regulatory approvals and legislations related to the Pulsed Electromagnetic Field Therapy Devices Market are also included in the report to let the key stakeholders frame their business policies accordingly.

Path-breaking trends in the Pulsed Electromagnetic Field Therapy Devices Market that have the potential of changing the competitive landscape also acquire an important place in the report. Highlighting on such aspects makes the report a knight in shining Armor for the key stakeholders in the Pulsed Electromagnetic Field Therapy Devices Market.

Some of the major players in the global pulsed electromagnetic field therapy devices market are EarthPulse, SEDONA Wellness LTD., Bedfont Scientific Ltd., Innovative Medicine, LLC., ONDAMED, Orthofix Holdings, Inc., Pulse Centers, Curatronic, Oxford Medical Instruments, Pulsed Energy Technologies LLC., SomniResonance, Curatronic Ltd., MediCrystal and others.

Some of the insights and market estimations that make this study unique in approach and effective in guiding stakeholders in understanding the growth dynamics. The study provides:

Details regarding latest innovations and development in Pulsed Electromagnetic Field Therapy Devices Market and how it is gaining customer traction during the forecast period.
Analysis about the customer demand of the products and how it is likely to evolve in coming years.
Latest regulations enforced by government bodies and local agencies and their impact on growth of the Pulsed Electromagnetic Field Therapy Devices Market.
Insights about adoption of new technologies and its influence on the Pulsed Electromagnetic Field Therapy Devices Market expansion
Overview of the impact of COVID-19 on Pulsed Electromagnetic Field Therapy Devices Market and economic disruptions caused by the pandemic.
Evaluates post-pandemic impact on the market growth during the forecast period.

Browse More Reports by Fact.MR : http://www.globenewswire.com/en/news-release/2019/07/18/1884617/0/en/Airsoft-Guns-Market-Continues-to-See-Hegemony-of-Electric-Variants-as-Preference-for-Selective-Fire-Capabilities-Prevails-Fact-MR-Study.html

Explore Fact.MR’s Healthcare Reports
Hospital Asset Management Market: Delve into Fact.MR’s extensive study on the hospital asset management market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Aneurysm Clips Market: The global aneurysm clips market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Aptamers Market: Fact.MR’s global aptamers market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Tags Pulsed Electromagnetic Field Therapy Devices Market, Pulsed Electromagnetic Field Therapy Devices Market insight, Pulsed Electromagnetic Field Therapy Devices Market Share, Pulsed Electromagnetic Field Therapy Devices Market size

Pharmaceutical

Pediatric HIV Infection Treatment Market to Witness a Tremendous Growth Due to COVID-19 Pandemic – Exclusive Report by Fact.MR

Fact.MR, a global research and consulting firm, in the updated edition of the report, opines Pediatric HIV Infection Treatment market to grow at a steady rate in 2021 & beyond. The Growth is primarily propelled by growing prevalence of HIV infection in kids. Active participation of international and national government bodies to support the research on HIV infection treatment drugs is accountable to boost demand amid the forecast period.

This Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key reasons behind the increasing demand of Pediatric HIV Infection Treatment. Pediatric HIV Infection Treatment market drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review are addressed in the Pediatric HIV Infection Treatment market survey report. The survey report provides a comprehensive analysis of Pediatric HIV Infection Treatment market key trends and insights on Pediatric HIV Infection Treatment market size and share.

To Get In-depth Insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=874

The global market for pediatric HIV infection treatment is segmented on basis of HIV infection types, treatment, distribution channel and geography:

Segmentation by Type

Not symptomatic
Mildly symptomatic
Moderately symptomatic
Severely symptomatic

Segmentation by Treatment

Antiretroviral (ARV) drugs
Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Protease Inhibitor (PI)
Integrase Strand Transfer Inhibitor (INSTI)
Others
Supportive care

Segmentation by Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drugstore
e-commerce

On the basis of geography, global pediatric HIV infection treatment market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific excluding China, China and Middle East & Africa. North America is expected to witness faster revenue growth in comparison with markets in other regions owing to higher infection rate amongst children and a large number of pediatric population suffering from HIV infection.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=874

Pediatric HIV Infection Treatment Market: Key Players
Examples of some of the key players present in the global pediatric HIV infection treatment market are GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, ViiV Healthcare, Camber Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Apotex Inc., and others.

How Huge is the US Pediatric HIV Infection Treatment Industry?
The US is anticipated to foresee faster revenue advance in contrast with markets in other regions on account of higher infection rate amid children as well as a huge number of pediatric population suffering from HIV infection.

China and India are also the fastest expanding regions in the as a result of higher involvement of non-government and government bodies in endorsing HIV infection treatment campaigns.

On the other hand, as 90% of children living with HIV exist in sub-Saharan Africa, as well as HIV/AIDS is the prevelant cause of death for adolescents in Africa has fast-tracked the need for infection treatment.

Key questions answered in Pediatric HIV Infection Treatment Market Survey Report:

What is the current scenario and key trends in Pediatric HIV Infection Treatment Market?
What are the key strategies companies are adopting to increase their consumer base?
What are the key categories within the Pediatric HIV Infection Treatment segments and their future potential?
What are the major Pediatric HIV Infection Treatment Market drivers and their expected impact during the short, medium, and long terms?
What is the Pediatric HIV Infection Treatment Market size and what are the opportunities for the key players?

Read More Trending and Similar Reports from Fact.MR – https://www.biospace.com/article/increasing-dental-complications-amid-the-elderly-driving-demand-for-dental-restoratives-finds-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain:
Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.

At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.

Wearable Cardiac Monitors market: Fact.MR’s global wearable cardiac monitor’s market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Tags Pediatric HIV Infection Treatment Market, Pediatric HIV Infection Treatment Market Insight, Pediatric HIV Infection Treatment Market Share, Pediatric HIV Infection Treatment Market Size, Pediatric HIV Infection Treatment Market Value